The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Novikov F.V.

Kursk State Medical University of the Ministry of Health of Russia

Luneva I.S.

Kursk State Medical University of the Ministry of Health of Russia

Starkova O.A.

Kursk State Medical University of the Ministry of Health of Russia

Molecular genetic profile of seromucinous ovarian tumors

Authors:

Novikov F.V., Luneva I.S., Starkova O.A.

More about the authors

Journal: Russian Journal of Archive of Pathology. 2021;83(1): 53‑57

DOI: 10.17116/patol20218301153

Read: 3037 times

Download PDF (RU)
Contact the author
Table of contents

MOLECULAR GENETIC PROFILE OF SEROMUCINOUS OVARIAN TUMORS
MOLECULAR GENETIC PROFILE OF SEROMUCINOUS OVARIAN TUMORS

To cite this article:

Novikov FV, Luneva IS, Starkova OA. Molecular genetic profile of seromucinous ovarian tumors. Russian Journal of Archive of Pathology. 2021;83(1):53‑57. (In Russ.)
https://doi.org/10.17116/patol20218301153

 
Подписка 2026 Архив патологии (Russian Journal of Archive of Pathology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Seromucinous tumors belong to a group of ovarian epithelial tumors. They were originally described as tumors characterized by Müllerian endocervical differentiation. Molecular genetic studies have indicated these tumors as endometriosis-associated tumors due to the presence of ARID1 gene mutations. However, the histogenesis of these neoplasms is still unstudied.

Keywords:

ovarian epithelial tumors
endometriosis-associated ovarian tumors
histogenesis of ovarian tumors

Authors:

Novikov F.V.

Kursk State Medical University of the Ministry of Health of Russia

Luneva I.S.

Kursk State Medical University of the Ministry of Health of Russia

Starkova O.A.

Kursk State Medical University of the Ministry of Health of Russia

Received:

18.08.2020

Accepted:

16.11.2020

Close metadata

References:

  1. Kurman R. WHO Classification of tumours of female reproductive organs. Lyon: IARC; 2014.
  2. Fox H, Langley FA. Tumors of the ovary. Chicago: William Heinemann/Year Book; 1976.
  3. Rutgers JL, Scully RE. Rutgers J, Scully R. Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis. Cancer. 1988;61(2):340-348. https://doi.org/10.1002/1097-0142(19880115)61:2<340::AID-CNCR2820610225>3.0.CO;2-U "> 3.0.CO;2-U" target="_blank">https://doi.org/10.1002/1097-0142(19880115)61:2<340::AID-CNCR2820610225>3.0.CO;2-U
  4. Rutgers JL, Scully RE. Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy of mullerian type. A clinicopathologic analysis. Cancer. 1988;61(3):546-554. https://doi.org/10.1002/1097-0142(19880201)61:3<546::AID-CNCR2820610321>3.0.CO;2-I "> 3.0.CO;2-I" target="_blank">https://doi.org/10.1002/1097-0142(19880201)61:3<546::AID-CNCR2820610321>3.0.CO;2-I
  5. Tavassoli F, Devilee P. Pathology and genetics of tumours of the breast and female genital organs. Lyon: WHO; 2003.
  6. Shappell HW, Riopel MA, Smith Sehdev AE, Ronnett BM, Kurman RJ. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas. Am J Surg Pathol. 2002;26(12):1529-1541. https://doi.org/10.1097/00000478-200212000-00001
  7. Kurman RJ, Shih IeM. Seromucinous tumors of the ovary. What’s in a name? Int J Gynecol Pathol. 2016;35(1):78-81.  https://doi.org/10.1097/pgp.0000000000000266
  8. Nagamine M, Mikami Y. Ovarian seromucinous tumors: pathogenesis, morphologic spectrum, and clinical issues. Diagnostics (Basel). 2020;10(2):77. 
  9. Rutgers JKL. Mullerian mucinous/mixed epithelial (seromucinous) ovarian tumors. AJSP: Reviews & Reports. 2016;21(5):206-213. 
  10. Munjishvili V, Barabadze E, Musashvili T, Gachechiladze M, Burkadze G. Morphophenotypic characteristics of ovarian serous borderline tumors. Georgian Med News. 2019;290:20-25. 
  11. Mills AM, Shanes ED. Mucinous ovarian tumors. Surg Pathol Clin. 2019;12(2):565-585.  https://doi.org/10.1016/j.path.2019.01.008
  12. Hauptmann S, Friedrich K, Redline R, Avril S. Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria. Virchows Arch. 2017;470(2):125-142.  https://doi.org/10.1007/s00428-016-2040-8
  13. Vang R, Gown AM, Barry TS, Wheeler DT, Ronnett BM. Ovarian atypical proliferative (borderline) mucinous tumors: gastrointestinal and seromucinous (endocervical-like) types are immunophenotypically distinctive. Int J Gynecol Pathol. 2006;25(1):83-89.  https://doi.org/10.1097/01.pgp.0000177125.31046.fd
  14. Yasunaga M, Ohishi Y, Oda Y, Misumi M, Iwasa A, Kurihara S, Nishimura I, Okuma E, Kobayashi H, Wake N, Tsuneyoshi M. Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors. Hum Pathol. 2009;40(7): 965-974.  https://doi.org/10.1016/j.humpath.2008.12.006
  15. Hamada T, Kiyokawa T, Nomura K, Hano H. Immunohistochemical analysis of reserve cell-like cells of ovarian müllerian mucinous/mixed epithelial borderline tumor. Int J Gynecol Pathol. 2008;27(2):199-206.  https://doi.org/10.1097/pgp.0b013e31815b077b
  16. Wu CH, Mao TL, Vang R, Ayhan A, Wang TL, Kurman RJ, Shih IeM. Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A. Int J Gynecol Pathol. 2012;31(4):297-303.  https://doi.org/10.1097/pgp.0b013e31823f8482
  17. Wilsker D, Probst L, Wain HM, Maltais L, Tucker PW, Moran E. Nomenclature of the ARID family of DNA-binding proteins. Genomics. 2005;86(2):242-251.  https://doi.org/10.1016/j.ygeno.2005.03.013
  18. Guan B, Wang TL, Shih IeM. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer Res. 2011;71(21):6718-6727. [published correction appears in Cancer Res. 2012;72(12):3116]. https://doi.org/10.1158/0008-5472.can-11-1562
  19. Maeda D, Shih IeM. Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms. Adv Anat Pathol. 2013;20(1):45-52.  https://doi.org/10.1097/pap.0b013e31827bc24d
  20. Ding XH, Tian X, Wang LQ, Wang Y, Liu AJ. Expression of ARID1A in ovarian seromucinous neoplasms and its clinicopathological significance. Zhonghua Bing Li Xue Za Zhi. 2020;49(6):588-593.  https://doi.org/10.3760/cma.j.cn112151-20200224-00130
  21. Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, Yang W, Heravi-Moussavi A, Giuliany R, Chow C, Fee J, Zayed A, Prentice L, Melnyk N, Turashvili G, et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med. 2010;363(16):1532-1543. https://doi.org/10.1056/NEJMoa1008433
  22. Jones S, Wang TL, Shih IeM, Mao TL, Nakayama K, Roden R, Glas R, Slamon D, Diaz LA Jr, Vogelstein B, Kinzler KW, Velculescu VE, Papadopoulos N. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science. 2010;330(6001):228-231.  https://doi.org/10.1126/science.1196333
  23. Ayhan A, Mao TL, Seckin T, Wu CH, Guan B, Ogawa H, Futagami M, Mizukami H, Yokoyama Y, Kurman RJ, Shih IeM. Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma. Int J Gynecol Cancer. 2012;22(8):1310-1315. https://doi.org/10.1097/IGC.0b013e31826b5dcc
  24. Levakov SA, Gromova T, Kedrova AG, Sheshukova NA. Endometriosis-associated ovarian cancer. Opukholi zhenskoi reproduktivnoi sistemy/Tumors of Female Reproductive System. 2016;12(4):47-51. (In Russ.). https://doi.org/10.17650/1994-4098-2016-12-4-47-51
  25. Kurman RJ, Shih IeM. The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded. Am J Pathol. 2016;186(4):733-747.  https://doi.org/10.1016/j.ajpath.2015.11.011
  26. Kim KR, Choi J, Hwang JE, Baik YA, Shim JY, Kim YM, Robboy SJ. Endocervical-like (Müllerian) mucinous borderline tumours of the ovary are frequently associated with the KRAS mutation. Histopathology. 2010;57(4):587-596.  https://doi.org/10.1111/j.1365-2559.2010.03673.x
  27. Guerra C, Mijimolle N, Dhawahir A, Dubus P, Barradas M, Serrano M, Campuzano V, Barbacid M. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell. 2003;4(2):111-120.  https://doi.org/10.1016/s1535-6108(03)00191-0
  28. Sato N, Tsunoda H, Nishida M, Morishita Y, Takimoto Y, Kubo T, Noguchi M. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res. 2000;60(24):7052-7056.
  29. Wu RC, Chen SJ, Chen HC, Tan KT, Jung SM, Lin CY, Chao AS, Huang KG, Chou HH, Chang TC, Chao A, Lai CH. Comprehensive genomic profiling reveals ubiquitous KRAS mutations and frequent PIK3CA mutations in ovarian seromucinous borderline tumor. Mod Pathol. Jul 2 2020. https://doi.org/10.1038/s41379-020-0611-3
  30. Rambau PF, McIntyre JB, Taylor J, Lee S, Ogilvie T, Sienko A, Morris D, Duggan MA, McCluggage WG, Köbel M. Morphologic reproducibility, genotyping, and immunohistochemical profiling do not support a category of seromucinous carcinoma of the ovary. Am J Surg Pathol. 2017;41(5):685-695.  https://doi.org/10.1097/PAS.0000000000000812
  31. Ng A, Barker N. Ovary and fimbrial stem cells: biology, niche and cancer origins. Nat Rev Mol Cell Biol. 2015;16(10):625-638.  https://doi.org/10.1038/nrm4056
  32. Karpathiou G, Chauleur C, Corsini T, Venet M, Habougit C, Honeyman F, Forest F, Peoc’h M. Seromucinous ovarian tumor A comparison with the rest of ovarian epithelial tumors. Ann Diagn Pathol. 2017;27:28-33.  https://doi.org/10.1016/j.anndiagpath.2017.01.002
  33. Kurman RJ, Shih I. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer — shifting the paradigm. Hum Pathol. 2011;42(7):918-931.  https://doi.org/10.1016/j.humpath.2011.03.003
  34. Novikov FV, Luneva IS, Mishina ES, Mnikhovich MV. Morphological basics of ovarian tumor histogenesis. Opukholi zhenskoi reproduktivnoi sistemy/Tumors of Female Reproductive System. 2020; 16(1):78-84. (In Russ.). https://doi.org/10.17650/1994-4098-2020-16-1-78-84
  35. Karpathiou G, Chauleur C, Venet M, Clemenson A, Peoc’h M. Pathology of the fallopian tube: tubal involvement by ovarian tumors and incidental findings in the nontumoral setting. Pathobiology. 2020;87(1):37-44.  https://doi.org/10.1159/000505406
  36. Ershov VA, Mikhailov VM, Chirsky VS. Reserve and basal cells of the cervical epithelium as a source of cervical neoplasia associated with human papilloma viruses. Genes & Cells. 2019;14(1):80-84. (In Russ.). https://doi.org/10.23868/201903011
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.